Med J Chin PLA, Vol. 43, No. 3, March 1, 2018 251 [ ] 2012 6 2013 8 ( 500m n=193) ( 500m) 2h ( 3700m) 1d( n=147) 7d( n=122) 3 (PLT) (PDW) (PCT) (MPV) (P<0.05)PLT PDW PCT (P<0.05) (PAF) (Epi) (P<0.05) PAF Epi (P<0.05) (5-HT) 3 (P>0.05) Pearson PLT (SpO 2 ) (P<0.05) PLT PDW PCT SpO 2 [ ] [ ] R339.54; R821.52; R331.143 [ ] A [ ] 0577-7402(2018)03-0251-06 [DOI] 10.11855/j.issn.0577-7402.2018.03.13 Influence of acute high altitude exposure and short-term acclimation on platelet-associated parameters in healthy young man KE Jing-bin, LI Jia-bei, ZHANG Ji-hang, BIAN Shi-zhu, YANG Jie, LIU Chuan, CHEN Can, ZHANG Chen, YU Jie, JIN Jun, HUANG Lan* Department of Cardiology, Xinqiao Hospital, Army Medical University, Institute of Cardiovascular Diseases of PLA, Chongqing 400037, China * Corresponding author, E-mail: huanglan260@126.com This work was supported by the National Natural Science Foundation of China (81470300, 81730054) [Abstract] Objective To explore the effect of high altitude exposure and short-term acclimation on the platelet-associated parameters by studying the changes of platelet-associated parameters in healthy young man. Methods Four hundred and sixtytwo young men were recruited from Chengdu (the elevation of 500m) during Jun. 2012 to Aug. 2013 according to the inclusion and exclusion criteria, of which 193 had been living in Chengdu (plain group), and 269 flew from Chengdu to Lhasa (3700m) in 2 hours, and then 147 of them were exposed in the high altitude for 1 day (acute high altitude exposure group), and another 122 for 7 days (short-term acclimation group). The demographic data were collected and the blood routine and platelet-associated parameters were measured of all the participants, and then the information collected were compared between the 3 groups. Results Compared to the plain group, the platelet count (PLT), platelet distribution width (PDW) and plateletcrit (PCT) reduced and the mean platelet volume (MPV) increased significantly (P<0.05) in the acute high altitude exposure group; while all the indexes in short-term acclimation group returned to approach the levels in the plain group, but statistical differences still existed in PLT, PDW and PCT (P<0.05). The platelet activating factor (PAF) and epinephrine (Epi) decreased markedly in acute high altitude exposure group than in plain group (P<0.05); while in short-term acclimation group, the PAF returned to approach the level in plain group, and the Epi was further down (P<0.05). In addition, no marked difference of 5-HT level was observed in the 3 groups (P>0.05). Pearson correlation analysis indicated that high altitude-induced reduction of oxygen saturation (SpO 2 ) was positively related to the changes of PLT. Conclusions Acute high altitude exposure may reduce PLT, PDW and PCT levels, but elevate MPV and enhance the [ ] (81470300) (81730054) [ ] [ ] 400037 ( ) [ ] E-mail huanglan260@126.com
252 2018 3 1 43 3 platelet activity. The reduction of SpO 2 might be associated with the changes of PLT, PDW and PCT. Platelet-associated parameters may be recovered to normal with a compensatory effect after short-term acclimation. [Key words] high altitude; acclimation; platelet; platelet activity 2500m [1-3] [4-10] [11-14] [15] [16] [17-28] 1 1.1 2012 6 2013 8 462 18~40 1.2 ( 500m n=193) ( 500m) 2h ( 3700m) 1d( n =147) 7d( n =122) (heart rate HR) (blood pressure BP) (pulse oxygen saturation SpO 2 ) 3 1.2.1 ( ) (HR BP SpO 2 ) 1.2.2 HR BP OMRON HEM-6200 ( ) SpO 2 NONIN ONYX 9500 ( ) BC-3000 plus ( ) ELISA (5-hydroxytryptamine 5-HT) (platelet activating factor PAF) (Epinephrine Epi) ELISA 1.3 SPSS 19.0 x±s 3 LSD-t Kruskal-Wallis Nemenyi % χ 2 SpO 2 Pearson P<0.05 2 2.1 462 3 (body mass index BMI) (P>0.05) (systolic blood pressure SBP) (diastolic blood pressure DBP) HR SpO 2 (P<0.05 1) 2.2 (WBC) (PLT) (platelet distribution width PDW) (plateletcrit PCT) (P<0.05) (hemoglobin HGB) (RBC) (mean platelet volume MPV) (P<0.05) PLT PDW PCT (P<0.05) MPV (P<0.05)
Med J Chin PLA, Vol. 43, No. 3, March 1, 2018 253 Item 1 Tab.1 Comparison of demographic characteristics and physiological parameters between each group Plain group (n=193) Acute high altitude exposure group (n=147) Short-term acclimation group (n=122) F or χ 2 value Age (year) 22.02 2.38 21.42 2.19 21.28 2.23 3.352 0.631 BMI (kg/m 2 ) 21.76 2.41 21.30 2.09 21.4 1.9 2.352 0.308 Smoking [n(%)] 121(62.7) 102(69.4) 84(68.9) 2.106 0.349 Drinking [n(%)] 143(74.1) 109(74.1) 88(72.1) 0.182 0.913 SBP (mmhg) 114.38 10.66 118.19 11.25 120.71 10.78 26.129 0.001 DBP (mmhg) 72.70 11.70 78.48 8.92 80.84 10.31 6.945 0.001 HR (beat/min) 63.70 9.89 83.58 10.81 85.39 11.06 17.286 0.001 SpO 2 (%) 99.36 0.97 89.02 2.63 88.82 3.23 26.56 0.001 BMI. Body mass index; SBP. Systolic blood pressure; DBP. Diastolic blood pressure; HR. Heart rate; SpO 2. Oxyhemoglobin saturation P value HGB RBC (P<0.05 2) 2 (x±s) Tab.2 Comparison of platelet and blood routine parameters between each group (x±s) Item 2.3 PAF Epi (P<0.05) 5-HT (P>0.05) 5-HT PAF (P<0.05) (P>0.05) Epi 3 (P<0.05 3) 2.4 SpO 2 PLT MPV PDW PCT SpO 2 5-HT PAF Epi PLT PDW PCT SpO 2 (P<0.05) PLT MPV 5-HT PAF Epi (P>0.05 4) 3 Plain group (n=193) Acute high altitude exposure group (n=147) Short-term acclimation group (n=122) WBC (10 9 /L) 7.80 2.38 6.14 1.38 (1) 6.18 1.51 (1) HGB (g/l) 141.32 10.65 159.88 20.41 (1) 171.38 13.12 (1)(2) RBC (10 12 /L) 4.69 0.48 4.98 0.61 (1) 5.13 0.41 (1)(2) PLT (10 9 /L) 200.56 50.00 156.12 37.84 (1) 188.76 42.19 (1)(2) MPV (fl) 9.72 1.05 10.18 0.78 (1) 9.72 0.72 (2) PDW (%) 16.26 0.47 15.81 0.29 (1) 16.01 0.32 (1)(2) PCT (%) 0.19 0.04 0.16 0.03 (1) 0.18 0.04 (1)(2) WBC. White blood cell; HGB. Hemoglobin; RBC. Red blood cell; PLT. Platelet; MPV. Mean platelet volume; PDW. Platelet distribution width; PCT. Plateletcrit; (1)P<0.05 compared with plain group; (2) P<0.05 compared with acute high altitude exposure group 3 (ng/ml x±s) Tab.3 Platelet-associated parameters in the serum between each group (ng/ml, x±s) Item Plain group (n=193) Acute high altitude exposure group (n=147) Short-term acclimation group (n=122) 5-HT 95.0 39.5 84.6 34.4 111.9 20.4 (2) PAF 9.4 1.7 8.1 1.3 (1) 9.7 1.9 (2) Epi 54.2 22.3 43.4 19.1 (1) 34.4 19.7 (1)(2) 5-HT. 5-hydroxytryptamine; PAF. Platelet activating factor; Epi. Epinephrine; (1)P<0.05 compared with plain group; (2)P<0.05 compared with acute high altitude exposure group 4 Tab.4 Pearson correlation of platelet parameters Item Correlation PLT MPV PDW PCT Correlation coefficient 0.270 0.007 0.358 0.314 SpO 2 P value <0.001 0.896 <0.001 <0.001 5-HT PAF Correlation coefficient 0.029 0.014 0.152 0.051 P value 0.878 0.942 0.416 0.787 Correlation coefficient 0.119 0.018 0.021 0.152 P value 0.447 0.911 0.894 0.331 Correlation coefficient 0.007 0.001 0.222 0.001 Epi P value 0.944 0.995 0.032 0.994 PLT. Platelet; MPV. Mean platelet volume; PDW. Platelet distribution width; PCT. Plateletcrit; SpO 2. Oxyhemoglobin saturation; 5-HT. 5-hydroxytryptamine; PAF. Platelet activating factor; Epi. Epinephrine SpO 2 PLT PDW PCT WBC MPV PLT PDW PCT WBC MPV WBC PLT PDW PCT HGB RBC HGB RBC
254 2018 3 1 43 3 PAF Epi PAF Epi 5-HT SBP DBP HR SpO 2 SBP DBP HR SpO 2 SpO 2 PLT PDW PCT SpO 2 PLT MPV [17-19] PLT MPV [20-21] PLT MPV [22-28] PLT MPV PLT MPV MPV [29] A2 b b/ a [30] [31] PLT MPV [32-33] P 5-HT Epi 5-HT PAF 5-HT Epi PAF 5-HT PAF Epi PLT SpO 2 PLT SpO 2 Vij [24] [33] HGB RBC [19] PLT Lehmann [35] PLT PLT PDW PCT MPV PLT PDW PCT SpO 2 RBC HGB [14] [1] Imray C, Wright A, Subudhi A, et al. Acute mountain sickness: pathophysiology, prevention, and treatment[ J]. Prog Cardiovasc Dis, 2010, 52(6): 467-484. [2] Palmer BF. Physiology and pathophysiology with ascent to altitude[ J]. Am J Med Sci, 2010, 340(1): 69-77. [3] Weil WM, Glassner PJ, Bosco JA 3rd. High-altitude illness and muscle physiology[ J]. Bull NYU Hosp Jt Dis, 2007, 65(1): 72-77. [4] Ainslie PN, Burgess KR. Cardiorespiratory and cerebrovascular responses to hyperoxic and hypoxic rebreathing: Effects of acclimatization to high altitude[ J]. Respir Physiol Neurobiol,
Med J Chin PLA, Vol. 43, No. 3, March 1, 2018 255 2008, 161(2): 201-209. [5] Bartsch P, Gibbs JS. Effect of altitude on the heart and the lungs[ J]. Circulation, 2007, 116(19): 2191-2202. [6] Hainsworth R, Drinkhill MJ. Cardiovascular adjustments for life at high altitude[ J]. Respir Physiol Neurobiol, 2007, 158(2-3): 204-211. [7] Risso A, Turello M, Biffoni F, et al. Red blood cell senescence and neocytolysis in humans after high altitude acclimatization[ J]. Blood Cells Mol Dis, 2007, 38(2): 83-92. [8] Ding XH, Bian SZ, Yu J, et al. The roles of echocardiography in evaluation of acclimatization at high-altitude[ J]. Mil Med Sci, 2014, 38(4): 262-265. [,,,. [ J]., 2014, 38(4): 262-265.] [9] Zhang Y. Studies on the changes of hemoglobin at high altitude [ J]. J High Altitude Med, 2008, 18(2): 62-64. [. [ J]., 2008, 18(2): 62-64.] [10] Liu L, Xu G, Li P, et al. Analysis of physiology and biochemistry indicators of garrison and field training troops at high altitude[ J]. Med J Chin PLA, 2017, 42(10): 909-913. [,,,. [ J]., 2017, 42(10): 909-913.] [11] Anand AC, Saha A, Seth AK, et al. Symptomatic portal system thrombosis in soldiers due to extended stay at extreme altitude[ J]. J Gastroenterol Hepatol, 2005, 20(5): 777-783. [12] Anand AC, Jha SK, Saha A, et al. Thrombosis as a complication of extended stay at high altitude[ J]. Natl Med J India, 2001, 14(4): 197-201. [13] Jha SK, Anand AC, Sharma V, et al. Stroke at high altitude: Indian experience[ J]. High Alt Med Biol, 2002, 3(1): 21-27. [14] K o t wa l J, A p te C V, K o t wa l A, et al. High altitude: a hypercoagulable state: results of a prospective cohort study[ J]. Thromb Res, 2007, 120(3): 391-397. [15] Gao YQ, Luo DC, Niu WZ, et al. Standards and methods of evaluating high altitude acclimatization[ J]. J Third Mil Med Univ, 2001, 23(12): 1453-1454. [,,,. [ J]., 2001, 23(12): 1453-1454.] [16] Li M, Gao XB, Yu J, et al. Current situation and progression of objective auxiliary diagnosis for acute mountain sickness[ J]. Med J Chin PLA, 2013, 38(9): 777-780. [,,,. [ J]., 2013, 38(9): 777-780.] [17] Gao JG, Wang Y, Cai JF, et al. The changes of platelet parameters in new recruits experienced the first plateau exposure[ J]. Med J Chin PAPF, 2004, 15(2): 126-127. [,,,. [J]., 2004, 15(2): 126-127.] [18] Li SZ, Xue ZJ, Mou XB. Detection of serum thrombopoietin level in patients with plateau polycythemia[ J]. Chin J Hematol, 1999, 20(11): 566. [,,. [J]., 1999, 20(11): 566.] [19] Gao JG, Wei HY, Xu FX, et al. Study on the mechanism of changes of platelet parameters in subjects rapidly moved to high altitude area[ J]. Lab Med Clin, 2013, 10(1): 43-45. [,,,. [ J]., 2013, 10(1): 43-45.] [20] Lin J, Zhao J, Qin J, et al. Analysis of complete blood count of soldiers after rush into plateau[ J]. J Prev Med Chin PLA, 2016, 34(6): 809-811. [,,,. [ J]., 2016, 34(6): 809-811.] [21] Wang YY, Wu LJ. Effect of high altitude hypoxia environment on peripheral blood cells of soldier[ J]. Int J Lab Med, 2015, 36(19): 2817-2818. [,. [ J]., 2015, 36(19): 2817-2818.] [22] Chatterji JC, Ohri VC, Das BK, et al. Platelet count, platelet aggregation and fibrinogen levels following acute induction to high latitude (3200 and 3771 metres)[ J]. Thromb Res, 1982, 26(3): 177-182. [23] Gray GW, Bryan AC, Freedman MH, et al. Effect of altitude exposure on platelets[ J]. J Appl Physiol, 1975, 39(4): 648-652. [24] Vij AG. Effect of prolonged stay at high altitude on platelet aggregation and fibrinogen levels[ J]. Platelets, 2009, 20(6): 421-427. [25] Cao ZL, Yin SY, Ren YK, et al. The dynamic changes of several blood cell parameters in 100 youths exposed to high altitude[ J]. Tibetan J Med, 1999, 25(2): 6-8. [,,,. 100 [ J]., 1999, 25(2): 6-8.] [26] Zeng P, Chen WW, Wang C, et al. Detection and analysis of platelet parameters of youths acutely exposed to high altitude [ J]. Med J Natl Defend Forces South China, 2001, 11(5): 344-346. [,,,. [ J]., 2001, 11(5): 344-346.] [27] Fan LZ, Wang P, He LY, et al. Changes of blood cell indexes in training staff rushed into frigid plateau from tropical plain[ J]. Mil Med J S Chin, 2013, 27(2): 106-108. [,,,. [ J]., 2013, 27(2): 106-108.] [28] Ma QX, Ma CF. Clinical studies on the effects of altitude gradient on the parameters of blood cells and platelets in plateau roadmen[ J]. Clin Focus, 2009, 24(14): 1260-1261. [,. [ J]., 2009, 24(14): 1260-1261.] [29] Zhao YF, Liu L, Wu YH. Roles of platelet-associated factors in thrombotic disease[ J]. Chin J Biologicals, 2014, 27(4): 578-581. [,,. [ J]., 2014, 27(4): 578-581.] [30] Demir S, Avsar MK, Karakaya Z, et al. Increased mean platelet volume is associated with coronary artery ectasia[ J]. Postepy Kardiol Interwencyjnej, 2013, 9(3): 241-245. [31] Martin JF, Kristensen SD, Mathur A, et al. The causal role of megakaryocyte-platelet hyperactivity in acute coronary syndromes[ J]. Nat Rev Cardiol, 2012, 9(11): 658-670. [32] Qi YJ. The effect of plateau hypoxia on the platelet activity[ J]. J High Alt Med, 1995, 6(1): 22. [. [ J]., 1995, 6(1): 22.] [33] Xiao QL, Gao ZP, Chen GH, et al. The effect of plateau hypoxic environment on human platelet function[ J]. Med J Chin PAPF, 2005, 16(10): 758-759. [,,,. [J]., 2005, 16(10):
256 2018 3 1 43 3 758-759.] [34] Qiu YW, Song H, Zhao J, et al. The changes of platelet in high altitude environment and associated mechanisms[ J]. Med J Natl Defend Forces South Chin, 2015, 25(10): 1146-1148. [,,,. [ J]., 2015, 25(10): 1146-1148.] [35] Lehmann T, Url HM, Pleisch B, et al. Platelet count and function at high altitude and in high-altitude pulmonary edema[ J]. J App Physiol (1985), 2006, 100(2): 690-694. ( 2017-12-25 2018-01-25) ( )